- Home
- APLT vs PEBK Comparison
APLT vs PEBK Comparison
Compare APLT & PEBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- PEBK
- Stock Information
- Founded
- APLT 2016
- PEBK 1912
- Country
- APLT United States
- PEBK United States
- Employees
- APLT N/A
- PEBK N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- PEBK Major Banks
- Sector
- APLT Health Care
- PEBK Finance
- Exchange
- APLT Nasdaq
- PEBK Nasdaq
- Market Cap
- APLT 178.6M
- PEBK 162.7M
- IPO Year
- APLT 2019
- PEBK N/A
- Fundamental
- Price
- APLT $1.05
- PEBK $31.79
- Analyst Decision
- APLT Buy
- PEBK
- Analyst Count
- APLT 5
- PEBK 0
- Target Price
- APLT $4.13
- PEBK N/A
- AVG Volume (30 Days)
- APLT 11.8M
- PEBK 6.5K
- Earning Date
- APLT 11-06-2025
- PEBK 10-20-2025
- Dividend Yield
- APLT N/A
- PEBK 3.12%
- EPS Growth
- APLT N/A
- PEBK 4.77
- EPS
- APLT N/A
- PEBK 3.11
- Revenue
- APLT $121,000.00
- PEBK $84,131,000.00
- Revenue This Year
- APLT N/A
- PEBK N/A
- Revenue Next Year
- APLT $5,931.24
- PEBK N/A
- P/E Ratio
- APLT N/A
- PEBK $9.77
- Revenue Growth
- APLT N/A
- PEBK 6.23
- 52 Week Low
- APLT $0.30
- PEBK $23.74
- 52 Week High
- APLT $10.62
- PEBK $33.90
- Technical
- Relative Strength Index (RSI)
- APLT 66.45
- PEBK N/A
- Support Level
- APLT $0.56
- PEBK N/A
- Resistance Level
- APLT $1.32
- PEBK N/A
- Average True Range (ATR)
- APLT 0.17
- PEBK 0.00
- MACD
- APLT 0.05
- PEBK 0.00
- Stochastic Oscillator
- APLT 73.60
- PEBK 0.00
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About PEBK Peoples Bancorp of North Carolina Inc.
Peoples Bancorp of North Carolina Inc is a bank holding company. It is a state-chartered commercial bank serving Lincolnton, Newton, Denver, Catawba, Conover, Maiden, Claremont, Hiddenite, Hickory, Charlotte, Cornelius, Raleigh and Cary, North Carolina. It has a diversified loan portfolio with no foreign loans and few agricultural loans. The company's main source of income is dividends declared and paid by the Bank on its capital stock.